CC0 PUBLIC RECORD GRAPH Every score & timeline item links directly to its underlying U.S. FDA record (openFDA, ORA FOIA Reading Room, DECRS & OASIS).
Scoring Formula v2.0 & Legal Guardrails REST API v1
FG
GMPGraphv2.0
Global FDA Facility Graph & Co-Packer Intelligence
21 CFR Encyclopedia → 21 CFR 312.60
21 CFR 312.60 Bioresearch Monitoring 80 Annual Form 483 Citations

21 CFR 312.60 — FD-1572, protocol compliance

Plain-English Risk Theme: CAPA, Out-of-Specification (OOS) & Complaint Investigations · Official eCFR Text ↗
🛡️ Test Your SOP Against 21 CFR 312.60 →
Official FDA Inspectional Observation Template
"An investigation was not conducted in accordance with the [signed statement of investigator] [investigational plan]. Specifically, ***"
Plain-English Brand & QA Translation
Failure to thoroughly investigate unexplained batch discrepancies, Out-of-Specification lab results, or consumer complaints/adverse events and document root-cause Corrective and Preventive Actions (CAPA).
🚨 Why 15-Day Form 483 Responses Fail on 21 CFR 312.60:
FDA routinely rejects 15-day Form 483 responses for 21 CFR 312.60 when a facility merely states 'we revised our SOP and retrained personnel' without attaching: (1) the signed, effective-dated SOP, (2) photographic or batch-log proof of implementation, and (3) a retrospective impact assessment of all commercial lots manufactured over the prior 24 months within expiry.
✅ Standard 15-Day CAPA Remediation Blueprint:
  1. Immediate Containment (Days 1–3): Place affected raw materials or in-process lots on QA Hold and open formal CAPA under 21 CFR 312.60.
  2. Systemic Root-Cause & SOP Overhaul (Days 4–10): Deploy a closed-loop CAPA and OOS investigation SOP requiring root-cause determination within 30 business days, impact assessment on distributed lots, and effectiveness checks.
  3. Retrospective Lot Review & Effectiveness Check (Days 11–15): Test retention samples of distributed lots and schedule a 30/60/90-day QA audit to prove sustained compliance.

Copy-Paste Compliant SOP Clause Template (21 CFR 312.60)

FREE AUDIT-READY BOILERPLATE 
STANDARD OPERATING PROCEDURE — COMPLIANCE CLAUSE 21 CFR 312.60
1. PURPOSE: Establish mandatory cGMP controls satisfying 21 CFR 312.60 (FD-1572, protocol compliance).
2. REQUIREMENT: Deploy a closed-loop CAPA and OOS investigation SOP requiring root-cause determination within 30 business days, impact assessment on distributed lots, and effectiveness checks.
3. QA VERIFICATION & SIGN-OFF: Dual independent verification by Production and Quality Assurance Unit (QAU) is required prior to batch release. Any deviation or Out-of-Specification (OOS) result triggers a formal CAPA investigation within 24 hours.

FDA Investigators Who Frequently Cite 21 CFR 312.60

Marcus V. Delgado (Southwest Division (Dallas District)) →Elena R. Rostova (Pacific Southwest Division (Los Angeles District)) →David K. Chen (Northeast Division (New Jersey District)) →

Published Form 483s Citing 21 CFR 312.60

Indexed in FDA ORA Inspectional Observations dataset.